Bulk Pharmaceutical API Sources for HYPAQUE SODIUM 20%

Bulk Pharmaceutical API Sources for HYPAQUE SODIUM 20%

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		23672589
MP Biomedicals		102908
MolPort		MolPort-003-930-326
Ambinter		SBB057976
ChemMol		49414907

Bulk Active Pharmaceutical Ingredient (API) Sources for: HYPAQUE SODIUM 20%

Last updated: August 4, 2025

---

Introduction

HYPAQUE SODIUM 20%, a commercially available iodine-based contrast agent, is primarily used in diagnostic imaging procedures such as angiography, urography, and computed tomography (CT). Its effective function relies on the high purity of its active pharmaceutical ingredient (API), sodium amidotrizoate (also known as sodium diatrizoate). Securing reliable bulk API sources for HYPAQUE 20% is critical to ensuring product quality, regulatory compliance, and cost-effectiveness within the pharmaceutical supply chain. This report highlights key considerations for sourcing sodium amidotrizoate bulk APIs, reviews global suppliers, and examines regulatory and market factors influencing procurement decisions.

---

Understanding Sodium Amidotrizoate API

Sodium amidotrizoate is an iodinated contrast medium with a chemical structure designed for optimal radiopacity. Its synthesis involves complex organic chemistry processes with strict quality controls to achieve pharmaceutical-grade purity (usp, EP, or JP standards). The API's role in HYPAQUE SODIUM 20% formulation demands high purity levels, low impurity profiles, and consistent quality to meet safety and efficacy standards.

---

Global API Suppliers and Manufacturers

1. Major Pharmaceutical API Suppliers

Several pharmaceutical ingredient manufacturers specialize in iodinated contrast agents, with some focusing exclusively on APIs like sodium amidotrizoate. These suppliers typically have Good Manufacturing Practice (GMP) certifications, adhere to international pharmacopeia standards, and possess extensive experience in chemical synthesis, purification, and quality assurance.

2. Key Players

• Bracco Imaging S.p.A.
  As the originator of many iodinated contrast agents, Bracco provides various APIs and intermediates for contrast media manufacturing. Their vertically integrated supply chain ensures consistent API quality, though their direct API sales are often limited to internal manufacturing.

• Liebel-Flarsheim Company (now part of Dentsply Sirona Imaging)
  Historically involved in contrast agent formulations, their API segment now largely supplies the commercial formulations, but they sometimes partner for bulk API procurement.

• SINOSOURCE CHEMICAL & PHARMA
  A China-based manufacturer specializing in iodine compounds, including APIs for contrast media. They have expanded their capacity to meet global demands and comply with international standards.

• Yantai Janus Pharmaceuticals
  A Chinese pharmaceutical company producing iodinated contrast media APIs, with GMP certifications and export capabilities.

• Sichuan Kelun Pharmaceutical Co., Ltd.
  A well-established Chinese API producer offering iodinated contrast agent APIs, including sodium amidotrizoate.

• S. Clarity (India)
  An emerging supplier providing iodinated contrast media APIs, emphasizing quality and regulatory adherence.

3. Regional and Niche Suppliers

Other regional suppliers include European companies like Guerbet (France), which predominantly focus on finished products but sometimes assist with API bulk supplies through partnerships. Markets such as India and China are key hubs due to manufacturing scale and cost advantages.

---

Factors Influencing API Sourcing

1. Regulatory Compliance

Sourcing from API manufacturers with validated GMP certification, and with the documentation to meet FDA, EMA, or other regional regulatory standards, is essential. Ensuring their APIs adhere to pharmacopeia monographs (USP, EP, JP) reduces the risk of regulatory hurdles.

2. Quality and Purity

High API purity (>99%) with minimal residual solvents, heavy metals, or other impurities is non-negotiable. Analytical testing and batch release documentation should be scrutinized during vendor qualification.

3. Supply Chain Security

Long-term manufacturing capacity, supply stability, and contingency planning are critical, especially given the COVID-19 pandemic's impact on global logistics. Selecting suppliers with risk mitigation strategies ensures continuous supply.

4. Cost and Lead Time

Pricing varies significantly based on manufacturing scale, geopolitical factors, and quality certifications. Established suppliers might command premium prices but offer reliability and certification assurances.

5. Customization and Contract Manufacturing

Some suppliers offer custom synthesis or toll manufacturing services, enabling clients to develop APIs tailored to specific formulations or regulatory needs.

---

Regulatory and Market Dynamics

Increasing scrutiny around the sourcing of pharmaceutical APIs emphasizes transparency, compliance, and traceability. Regulatory agencies like the FDA and EMA require detailed documentation on manufacturing practices, Quality Agreements, and supplier qualification audits.

The Chinese API market continues to expand, driven by rising domestic production capacity and export capabilities, but concerns over regulatory standards persist, necessitating thorough due diligence when sourcing from these regions. Notably, some Chinese API manufacturers have faced GMP non-compliance issues; hence, verifications and certifications are paramount.

European manufacturers, although fewer in number, often offer APIs with rigorous quality assurance and regulatory backing, making them attractive albeit at higher costs.

---

Key Considerations for Procurement

• Verification of GMP Certification: Ensuring suppliers maintain current GMP compliance per relevant authorities.
• Quality Documentation: Batch records, Certificates of Analysis (CoA), stability data, and impurity profiles.
• Supply Agreements: Long-term contracts with clear scope, penalties, and contingency provisions.
• Certifications and Regulatory Status: API compliance with regional pharmacopeias and suitability for use in target markets.

---

Future Trends in API Sourcing for HYPAQUE SODIUM 20%

The ongoing global shift towards regional manufacturing and increasing regulatory standards will impact API sourcing strategies. Emphasis on supply chain resilience, quality assurance, and cost competitiveness will drive relationships with diversified suppliers. Moreover, bioequivalence and the possibility of developing alternative iodine-based contrast agents might reshape API demand and sourcing.

---

Conclusion

Securing a reliable supply of high-quality sodium amidotrizoate API remains pivotal for manufacturers of HYPAQUE SODIUM 20%. Leading suppliers from China, India, and Europe offer viable options, each with distinct advantages regarding cost, quality, and regulatory compliance. Strategic sourcing, underpinned by rigorous supplier qualification, regulatory adherence, and logistics planning, is essential to ensure uninterrupted supply and product integrity.

---

Key Takeaways

• Globally, China and India dominate the API supply landscape for iodinated contrast agents, including sodium amidotrizoate.
• Ensuring GMP certification and pharmacopeia compliance is critical when selecting API suppliers.
• Diversification of suppliers mitigates supply chain risks and enhances security.
• Supplier due diligence, including audit and verification of quality documentation, is crucial.
• Regulatory trends favor transparent, compliant, and traceable APIs, influencing sourcing decisions.

---

FAQs

1. What are the key qualities to look for in a sodium amidotrizoate API supplier?
Manufacturers must demonstrate GMP compliance, provide comprehensive quality documentation, ensure high purity levels (>99%), and possess proven regulatory approvals in target markets.

2. How does regional regulation affect API sourcing for HYPAQUE SODIUM?
Regulatory frameworks (FDA, EMA, CFDA, etc.) govern API quality, manufacturing practices, and documentation requirements. Suppliers must meet these standards to ensure market access and avoid compliance issues.

3. Are Chinese API manufacturers reliable for sourcing sodium amidotrizoate?
Many Chinese manufacturers are capable of producing high-quality APIs adhering to GMP standards, but due diligence is necessary. Verification of certifications and independent audits help ensure reliability.

4. What are the benefits of sourcing APIs from established European suppliers?
European suppliers often offer products with stringent quality control, comprehensive documentation, and regulatory acceptance, albeit at potentially higher costs.

5. Is the supply of sodium amidotrizoate API stable considering recent geopolitical changes?
Supply stability depends on supplier diversity, manufacturing capacity, and geopolitical factors. Building relationships with multiple qualified suppliers mitigates risks and ensures continuity.

---

Sources:

[1] Pharmacopoeias and API monographs (USP, EP, JP) on iodinated contrast agents
[2] Industry reports on global pharmaceutical API markets
[3] Regulatory agency guidance documents on API quality and supply chain management
[4] Supplier websites and certification disclosures
[5] Market analysis publications on Chinese and Indian API manufacturing capacities